PMC:7594251 / 103401-103580 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T21 34-42 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T22 140-144 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T30 140-144 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T50928 34-42 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T73305 48-55 Chemical denotes ligands http://purl.obolibrary.org/obo/CHEBI_52214
T694 63-72 Chemical denotes molecules http://purl.obolibrary.org/obo/CHEBI_25367
T6431 156-160 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T686 0-179 Sentence denotes The interactions between targets (proteins) and ligands (small molecules) can be analyzed independently of the biological systems by using ‘cell-based’ NMR drug design approaches.